載入...
Screening of Drugs to Treat 8p11 Myeloproliferative Syndrome Using Patient-Derived Induced Pluripotent Stem Cells with Fusion Gene CEP110-FGFR1
Induced pluripotent stem (iPS) cells provide powerful tools for studying disease mechanisms and developing therapies for diseases. The 8p11 myeloproliferative syndrome (EMS) is an aggressive chronic myeloproliferative disorder (MPD) that is caused by constitutive activation of fibroblast growth fact...
Na minha lista:
發表在: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4372437/ https://ncbi.nlm.nih.gov/pubmed/25803811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120841 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|